FLT4 and lung adenocarcinoma: In addition, IGF2BP2 enhances the RNA stability of Fms Related Tyrosine Kinase 4 (FLT4) via m6A modification, activating the PI3K-Akt signaling pathway in lung adenocarcinoma (LUDA).